Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899223 · ClinicalTrials.gov registry record
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
A clinical trial of Acute Leukemia and Myelodysplasia, sponsored by Alliance for Clinical Trials in Oncology.
- Active
- Registry status
- 1,500
- Enrollment target
- 20
- Study locations
NCT00899223 is a study of Acute Leukemia and Myelodysplasia that is active but no longer recruiting, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,500 participants, above the 422-participant average among 37 other Acute Leukemia trials with a reported enrollment target (255% higher). The trial reports 20 study locations across 6 states.
The verdict
NCT00899223, a study of Acute Leukemia and Myelodysplasia, is active but no longer recruiting, sponsored by Alliance for Clinical Trials in Oncology.
- ACTIVE NOT RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
As one of the nation's largest cooperative cancer treatment groups, the Alliance for Clinical Trials in Oncology (Alliance) is in a unique position to organize a Leukemia Tissue Bank. The member institutions diagnose hundreds of patients with leukemia or myelodysplastic syndrome each year, and uniformly treat these patients with chemotherapy regimens. The Alliance offers centralized data management for the clinical history, the classification of the leukemia and myelodysplastic syndrome, cytogenetics, flow cytometric analysis, treatment and follow-up. The highly skilled health care providers at each member institution are familiar with obtaining informed consent, completing data questionnaires and shipping specimens. There currently exists a central processing facility where samples are prepared for a variety of cellular and molecular studies. Hence, the patient resources, the health care providers, and a processing facility for a Leukemia Tissue Bank are all in place. What is needed, however, and is addressed in the current protocol, is a formal mechanism to procure bone marrow, blood and normal tissue from patients with hematologic malignancies who are to be enrolled on Alliance (Cancer and Leukemia Group B \[CALGB\]) treatment studies.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
Study Locations (20)
Illinois
- Illinois CancerCare - Bloomington - Bloomington
- St. Joseph Medical Center - Bloomington
- Illinois CancerCare - Canton - Canton
- University of Illinois Cancer Center - Chicago
- Veterans Affairs Medical Center - Chicago Westside Hospital - Chicago
- University of Chicago Cancer Research Center - Chicago
- Eureka Community Hospital - Eureka
California
- Camino Medical Group - Treatment Center - Mountain View
- - Pismo Beach
- Naval Medical Center - San Diego - San Diego
- UCSF Helen Diller Family Comprehensive Cancer Center - San Francisco
Florida
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital - Fort Lauderdale
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center - Jupiter
- CCOP - Mount Sinai Medical Center - Miami Beach
- Florida Hospital Cancer Institute at Florida Hospital Orlando - Orlando
Delaware
- Tunnell Cancer Center at Beebe Medical Center - Lewes
- CCOP - Christiana Care Health Services - Newark
District of Columbia
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center - Washington D.C.
- Washington Cancer Institute at Washington Hospital Center - Washington D.C.
Connecticut
- Helen and Harry Gray Cancer Center at Hartford Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 1996-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899223
The ClinicalTrials.gov registry entry for NCT00899223 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 422-participant average among 37 other Acute Leukemia trials with a reported enrollment target (255% higher). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Leukemia appearing as the primary indexed condition, and to 1 intervention - of which biologic sample preservation procedure is the first listed.
NCT00899223 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Illinois, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00899223 about?
NCT00899223 is a clinical study titled "Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes". As one of the nation's largest cooperative cancer treatment groups, the Alliance for Clinical Trials in Oncology (Alliance) is in a unique position to organize a Leukemia Tissue Bank. The member institutions diagnose hundreds of patients with leukemia or myelodysplastic syndrome each year, and unifo...
What is the current status of trial NCT00899223?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 1996-05.
What conditions does trial NCT00899223 study?
This clinical trial studies the following conditions: Acute Leukemia, Myelodysplasia, Chronic Leukemia.
What interventions are being tested in trial NCT00899223?
The interventions under investigation include: biologic sample preservation procedure (OTHER).
Who is sponsoring clinical trial NCT00899223?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00899223 being conducted?
This trial has 20 study locations across California, Connecticut, Delaware, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
RECRUITING · Phase 2
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
RECRUITING · Phase 2
-
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
RECRUITING · Phase 1
-
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
RECRUITING · Phase 2
-
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.